AAAAAA

   
Results: 1-9 |
Results: 9
IMPROVED ORAL BIOAVAILABILITY OF THE HYPOCHOLESTEROLEMIC DMP-565 IN DOGS FOLLOWING ORAL DOSING IN OIL AND GLYCOL SOLUTIONS
Authors: BURCHAM DL MAURIN MB HAUSNER EA HUANG SM
Citation: Dl. Burcham et al., IMPROVED ORAL BIOAVAILABILITY OF THE HYPOCHOLESTEROLEMIC DMP-565 IN DOGS FOLLOWING ORAL DOSING IN OIL AND GLYCOL SOLUTIONS, Biopharmaceutics & drug disposition, 18(8), 1997, pp. 737-742
IMPROVED CYCLIC UREA INHIBITORS OF THE HIV-I PROTEASE - SYNTHESIS, POTENCY, RESISTANCE PROFILE, HUMAN PHARMACOKINETICS AND X-RAY CRYSTAL-STRUCTURE OF DMP-450
Authors: HODGE CN ALDRICH PE BACHELER LT CHANG CH EYERMANN CJ GARBER S GRUBB M JACKSON DA JADHAV PK KORANT B LAM PYS MAURIN MB MEEK JL OTTO MJ RAYNER MM REID C SHARPE TR SHUM L WINSLOW DL ERICKSONVIITANEN S
Citation: Cn. Hodge et al., IMPROVED CYCLIC UREA INHIBITORS OF THE HIV-I PROTEASE - SYNTHESIS, POTENCY, RESISTANCE PROFILE, HUMAN PHARMACOKINETICS AND X-RAY CRYSTAL-STRUCTURE OF DMP-450, Chemistry & biology, 3(4), 1996, pp. 301-314
SOLUBILITY BEHAVIOR, PHASE-TRANSITION, AND STRUCTURE-BASED NUCLEATIONINHIBITION OF ETANIDAZOLE IN AQUEOUS-SOLUTIONS
Authors: MAURIN MB ROWE SM FIELD KS SWINTOSKY RC HUSSAIN MA
Citation: Mb. Maurin et al., SOLUBILITY BEHAVIOR, PHASE-TRANSITION, AND STRUCTURE-BASED NUCLEATIONINHIBITION OF ETANIDAZOLE IN AQUEOUS-SOLUTIONS, Pharmaceutical research, 13(9), 1996, pp. 1401-1405
CHARACTERIZATION OF THE SALTS OF A CYCLIC RGD PEPTIDE
Authors: MAURIN MB ROWE SM ROCKWELL A FORIS CM HUSSAIN MA
Citation: Mb. Maurin et al., CHARACTERIZATION OF THE SALTS OF A CYCLIC RGD PEPTIDE, Pharmaceutical research, 13(3), 1996, pp. 481-484
PHYSICOCHEMICAL PROPERTIES OF A NONPEPTIDE CYCLIC UREA HIV PROTEASE INHIBITOR (DMP-323)
Authors: MAURIN MB VICKERY RD CARNEY RF HUSSAIN MA
Citation: Mb. Maurin et al., PHYSICOCHEMICAL PROPERTIES OF A NONPEPTIDE CYCLIC UREA HIV PROTEASE INHIBITOR (DMP-323), International journal of pharmaceutics, 144(1), 1996, pp. 99-106
A NOVEL ISOLATION METHOD OF A STABLE CRYSTALLINE SALT OF A CYCLIC RGDPEPTIDE ZWITTERION
Authors: MAURIN MB HUSSAIN MA
Citation: Mb. Maurin et Ma. Hussain, A NOVEL ISOLATION METHOD OF A STABLE CRYSTALLINE SALT OF A CYCLIC RGDPEPTIDE ZWITTERION, Pharmaceutical research, 12(11), 1995, pp. 1810-1812
IN-SITU CHARACTERIZATION OF NASAL LEUCINE-ENKEPHALIN DEGRADING AMINOPEPTIDASE - SUSCEPTIBILITY OF THE NASAL ENZYME TO BORONIC ACIDS AND PHOSPHORUS-CONTAINING PEPTIDE AND AMINO-ACID ISOSTERES
Authors: HUSSAIN MA MERSINGER L MAURIN MB KETTNER C
Citation: Ma. Hussain et al., IN-SITU CHARACTERIZATION OF NASAL LEUCINE-ENKEPHALIN DEGRADING AMINOPEPTIDASE - SUSCEPTIBILITY OF THE NASAL ENZYME TO BORONIC ACIDS AND PHOSPHORUS-CONTAINING PEPTIDE AND AMINO-ACID ISOSTERES, International journal of pharmaceutics, 117(2), 1995, pp. 181-188
SOLUBILIZATION OF NICARDIPINE HYDROCHLORIDE VIA COMPLEXATION AND SALTFORMATION
Authors: MAURIN MB ROWE SM KOVAL CA HUSSAIN MA
Citation: Mb. Maurin et al., SOLUBILIZATION OF NICARDIPINE HYDROCHLORIDE VIA COMPLEXATION AND SALTFORMATION, Journal of pharmaceutical sciences, 83(10), 1994, pp. 1418-1420
SOLUBILITY OF IONIZATION BEHAVIOR OF THE ANTIFUNGAL YRIDYL)PHENYLETHENYL)]-1H-1,2,4-TRIAZOLE-1-ETHANOL BISMESYLATE (XD405)
Authors: MAURIN MB VICKERY RD GERARD CA HUSSAIN M
Citation: Mb. Maurin et al., SOLUBILITY OF IONIZATION BEHAVIOR OF THE ANTIFUNGAL YRIDYL)PHENYLETHENYL)]-1H-1,2,4-TRIAZOLE-1-ETHANOL BISMESYLATE (XD405), International journal of pharmaceutics, 94(1-3), 1993, pp. 11-14
Risultati: 1-9 |